Medicaid insurance policies range from state-to-state. With the arrival of recent, GLP-1 drugs (and others) to deal with weight problems and chubby, there are probably important well being advantages to be gained. Nevertheless, are State Medicaid Companies truly overlaying these drugs? That is the query requested by Liu et al. (2024). They use information from public state Medicaid formulary and most well-liked drug record information to find out if a state lined FDA-approved anti-obesity drugs. The variety of reimbursed prescriptions for every antiobesity medicine was recognized from public 2011-2022 Medicaid State Drug Utilization information.
Usually, some however not all anti-obesity drugs are lined. Furthermore, the more practical GLP-1 drugs are usually solely lined if they’re used to deal with diabetes (fairly than chubby or weight problems).
Within the first quarter of 2023, 10 of 47 states (21%) with public most well-liked drug lists lined at the very least 1 antiobesity medicine; 5 (11%) had unrestricted protection of at the very least 1 antiobesity medicine…Individually, 39 states (83%) had unrestricted protection of at the very least 1 of the two diabetes variations of GLP-1 RAs.
The complete article is right here.